Search Results - "Staas, Jay K"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Use of Microsphere Technology for Targeted Delivery of Rifampin to Mycobacterium tuberculosis-Infected Macrophages by BARROW, E. L. W, WINCHESTER, G. A, STAAS, J. K, QUENELLE, D. C, BARROW, W. W

    Published in Antimicrobial Agents and Chemotherapy (01-10-1998)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Treatment of Tuberculosis Using a Combination of Sustained-Release Rifampin-Loaded Microspheres and Oral Dosing with Isoniazid by QUENELLE, Debra C, WINCHESTER, Gary A, STAAS, Jay K, BARROW, Esther L. W, BARROW, William W

    Published in Antimicrobial Agents and Chemotherapy (01-06-2001)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Protection Against Vaginal SIV Transmission with Microencapsulated Vaccine by Marx, Preston A., Compans, Richard W., Gettie, Agegnehu, Staas, Jay K., Gilley, Richard M., Mulligan, Mark J., Yamshchikov, Galina V., Chen, Dexiang, Eldridge, John H.

    “…Although protection in animal models against intravenous challenges with simian immunodeficiency virus (SIV) has been reported, no previous vaccines have…”
    Get full text
    Journal Article
  4. 4

    Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice by Barrow, Esther L W, Barrow, William W, Quenelle, Debra C, Westbrook, Louise, Winchester, Gary A, Staas, Jay K

    Published in Drug delivery (01-03-2007)
    “…Two poly(DL-lactide-co-glycolide) microsphere formulations (A, 10% wt/wt, and B, 23% wt/wt, 1-10 microns) were evaluated for intracellular delivery of…”
    Get more information
    Journal Article
  5. 5

    The fate of biodegradable microspheres injected into rat brain by Nicholas, Anthony P., McInnis, Carey, Gupta, Kiran B., Snow, William W., Love, Darryl F., Mason, David W., Ferrell, Teresa M., Staas, Jay K., Tice, Thomas R.

    Published in Neuroscience letters (26-04-2002)
    “…Biodegradable microspheres made with poly-[ d, l-lactide-co-glycolide] represent an evolving technology for drug delivery into the central nervous system. Even…”
    Get full text
    Journal Article
  6. 6

    Sustained release characteristics of rifampin-loaded microsphere formulations in nonhuman primates by Quenelle, Debra, Winchester, Gary A, Staas, Jay K, Hoskins, Darrel E, Barrow, Esther W, Barrow, William W

    Published in Drug delivery (01-01-2004)
    “…Controlled release rifampin-loaded microspheres were evaluated for the first time in nonhuman primates. Animals received either 2.0 g of a large formulation…”
    Get more information
    Journal Article
  7. 7

    Efficacy of Microencapsulated Rifampin inMycobacterium tuberculosis-Infected Mice by Quenelle, Debra C, Staas, Jay K, Winchester, Gary A, Barrow, Esther L. W, Barrow, William W

    Published in Antimicrobial Agents and Chemotherapy (01-05-1999)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Biodegradable microspheres as a vaccine delivery system by Eldridge, J H, Staas, J K, Meulbroek, J A, McGhee, J R, Tice, T R, Gilley, R M

    Published in Molecular immunology (01-03-1991)
    “…The utility of biodegradable and biocompatible microspheres as a vaccine delivery system for the induction of systemic and disseminated mucosal antibody…”
    Get more information
    Journal Article
  9. 9

    Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice by QUENELLE, D. C, STAAS, J. K, WINCHESTER, G. A, BARROW, E. L. W, BARROW, W. W

    Published in Antimicrobial agents and chemotherapy (01-05-1999)
    “…Rifampin is a first-line drug useful in the treatment of tuberculosis. By using biocompatible polymeric excipients of lactide and glycolide copolymers, two…”
    Get full text
    Journal Article
  10. 10

    Oral Immunization with Influenza Virus in Biodegradable Microspheres by Moldoveanu, Zina, Novak, Miroslav, Huang, Wen-Qiang, Gilley, Richard M., Staas, Jay K., Schafer, Dennis, Compans, Richard W., Mestecky, Jiri

    Published in The Journal of infectious diseases (01-01-1993)
    “…Polymeric microspheres were evaluated as an oral antigen delivery system for immunization with influenza virus. The immune responses obtained were compared…”
    Get full text
    Journal Article
  11. 11

    Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine by Greenway, Terrence E., Eldridge, John H., Ludwig, George, Staas, Jay K., Smith, Jonathan F., Gilley, Richard M., Michalek, Suzanne M.

    Published in Vaccine (01-08-1998)
    “…Venezuelan equine encephalomyelitis (VEE) virus, a member of the family Togaviridae, genus Alphavirus, causes disease in humans and equids. The virus is…”
    Get full text
    Journal Article
  12. 12

    Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response by Eldridge, J H, Meulbroek, J A, Staas, J K, Tice, T R, Gilley, R M

    “…Biodegradable and biocompatible microspheres have been investigated for their usefulness as a vaccine delivery system for both parenteral and enteral…”
    Get more information
    Journal Article
  13. 13

    Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine by Greenway, Terrence E., Eldridge, John H., Ludwig, George, Staas, Jay K., Smith, Jonathan F., Gilley, Richard M., Michalek, Suzanne M.

    Published in Vaccine (1995)
    “…Venezuelan equine encephalomyelitis (VEE) virus is a mosquito-borne arbovirus of major human health significance in the New World. Currently two forms of VEE…”
    Get full text
    Journal Article
  14. 14

    Induction of mucosal antibody responses by microsphere-encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model by Ishizaka, Sally T., Israel, Zimra R., Gettie, Agegnehu, Mishkin, Eric M., Staas, Jay K., Gilley, Richard M., Dailey, Peter J., Montefiori, David C., Marx, Preston A., Eldridge, John H.

    Published in Vaccine (16-07-1999)
    “…Male rhesus macaques were immunized mucosally with microsphere-encapsulated formalin-inactivated simian immunodeficiency virus (SIV) particles in a test of…”
    Get full text
    Journal Article